Nasdaq · CIK 0001729149
VMD VIEMED HEALTHCARE, INC.
Insider trading from SEC Form 4. Last filing Mar 20, 2026. Close $9.52 on Oct 9, 2026, +52% from the 52-week low and -23% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
VMDOct 9, 2026 · close 9.52
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at VIEMED HEALTHCARE, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Michael Moore President sell | $1.2M 136,802 shares | -8% | +57% from low-5% from high | |
| 29Weak | Jerome Cambre Vice President of Sales sell | $36k 4,880 shares | -5% | +24% from low-23% from high | |
| 53Moderate | Michael Moore President sell | $367k 50,090 shares | -28% | +25% from low-22% from high | |
| 15Weak | Nitin Kaushal director sell | $49k 7,048 shares | -5% | +9% from low-27% from high | |
| 58Moderate | Michael Moore President sell | $1.3M 181,316 shares | -100% | +9% from low-27% from high | |
| 32Weak | Nitin Kaushal director sell | $301k 42,952 shares | -32% | +9% from low-27% from high | |
| 26Weak | Nitin Kaushal director sell | $260k 30,000 shares | -20% | - | |
| 26Weak | Nitin Kaushal director sell | $256k 30,000 shares | -21% | - | |
| 33Weak | Randy E. Dobbs director sell | $337k 36,261 shares | -25% | - | |
| 37Weak | Nitin Kaushal director sell | $571k 60,000 shares | -38% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Michael Moore President | SOpen-market sale Common Sharesindirect: by Moore Faster LLC | -31,570 | $9.42 | $297k | 1,691,044 | Mar 20, 2026 |
| Mar 19, 2026 | Michael Moore President | SOpen-market sale Common Sharesindirect: by Moore Faster LLC | -40,232 | $9.21 | $371k | 1,650,812 | Mar 20, 2026 |
| Mar 20, 2026 | Michael Moore President | SOpen-market sale Common Sharesindirect: by Moore Faster LLC | -65,000 | $8.77 | $570k | 1,585,812 | Mar 20, 2026 |
| Jan 29, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Common Shares | +9,794 | - | - | 108,317 | Feb 2, 2026 |
| Jan 29, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Common Shares | +26,842 | - | - | 401,677 | Feb 2, 2026 |
| Jan 29, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Common Shares | +8,619 | - | - | 106,443 | Feb 2, 2026 |
| Jan 29, 2026 | Michael Moore President | MOption exercise Common Shares | +26,842 | - | - | 196,432 | Feb 2, 2026 |
| Jan 29, 2026 | William Frazier Chief Medical Officer | MOption exercise Common Shares | +2,334 | - | - | 74,016 | Feb 2, 2026 |
| Jan 29, 2026 | Jeremy Trahan General Counsel | MOption exercise Common Shares | +10,774 | - | - | 49,431 | Feb 2, 2026 |
| Jan 29, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Common Shares | +39,795 | - | - | 364,377 | Feb 2, 2026 |
| Jan 29, 2026 | Casey Hoyt Chief Executive Officer | FTax withholding Common Shares | -13,913 | $7.48 | $104k | 350,464 | Feb 2, 2026 |
| Jan 29, 2026 | Jerome Cambre Vice President of Sales | FTax withholding Common Shares | -2,355 | $7.48 | $18k | 104,088 | Feb 2, 2026 |
| Jan 29, 2026 | Jeremy Trahan General Counsel | FTax withholding Common Shares | -2,939 | $7.48 | $22k | 46,492 | Feb 2, 2026 |
| Jan 29, 2026 | William Todd Zehnder Chief Operating Officer | FTax withholding Common Shares | -11,368 | $7.48 | $85k | 390,309 | Feb 2, 2026 |
| Jan 29, 2026 | William Frazier Chief Medical Officer | FTax withholding Common Shares | -802 | $7.48 | $5,999 | 73,214 | Feb 2, 2026 |
| Jan 29, 2026 | Trae Fitzgerald Chief Financial Officer | FTax withholding Common Shares | -2,679 | $7.48 | $20k | 105,638 | Feb 2, 2026 |
| Jan 29, 2026 | Michael Moore President | FTax withholding Common Shares | -7,342 | $7.48 | $55k | 189,090 | Feb 2, 2026 |
| Jan 29, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Common Shares | +13,265 | - | - | 363,729 | Feb 2, 2026 |
| Jan 29, 2026 | Jeremy Trahan General Counsel | MOption exercise Common Shares | +3,591 | - | - | 50,083 | Feb 2, 2026 |
| Jan 29, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Common Shares | +2,873 | - | - | 106,961 | Feb 2, 2026 |
| Jan 29, 2026 | William Frazier Chief Medical Officer | MOption exercise Common Shares | +778 | - | - | 73,992 | Feb 2, 2026 |
| Jan 29, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Common Shares | +3,265 | - | - | 108,903 | Feb 2, 2026 |
| Jan 29, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Common Shares | +8,948 | - | - | 399,257 | Feb 2, 2026 |
| Jan 29, 2026 | Michael Moore President | MOption exercise Common Shares | +8,947 | - | - | 198,037 | Feb 2, 2026 |
| Jan 29, 2026 | Michael Moore President | DDisposition to issuer Common Shares | -8,947 | $7.48 | $67k | 189,090 | Feb 2, 2026 |
| Jan 29, 2026 | Trae Fitzgerald Chief Financial Officer | DDisposition to issuer Common Shares | -3,265 | $7.48 | $24k | 105,638 | Feb 2, 2026 |
| Jan 29, 2026 | Jerome Cambre Vice President of Sales | DDisposition to issuer Common Shares | -2,873 | $7.48 | $21k | 104,088 | Feb 2, 2026 |
| Jan 29, 2026 | Jeremy Trahan General Counsel | DDisposition to issuer Common Shares | -3,591 | $7.48 | $27k | 46,492 | Feb 2, 2026 |
| Jan 29, 2026 | William Todd Zehnder Chief Operating Officer | DDisposition to issuer Common Shares | -8,948 | $7.48 | $67k | 390,309 | Feb 2, 2026 |
| Jan 29, 2026 | Casey Hoyt Chief Executive Officer | DDisposition to issuer Common Shares | -13,265 | $7.48 | $99k | 350,464 | Feb 2, 2026 |
| Jan 29, 2026 | William Frazier Chief Medical Officer | DDisposition to issuer Common Shares | -778 | $7.48 | $5,819 | 73,214 | Feb 2, 2026 |
| Jan 29, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Restricted Stock Unitsderivative | -8,619 | $0.00 | $0 | 8,619 | Feb 2, 2026 |
| Jan 29, 2026 | William Frazier Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | -2,334 | $0.00 | $0 | 2,334 | Feb 2, 2026 |
| Jan 29, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -26,842 | $0.00 | $0 | 26,842 | Feb 2, 2026 |
| Jan 29, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -9,794 | $0.00 | $0 | 9,794 | Feb 2, 2026 |
| Jan 29, 2026 | Jeremy Trahan General Counsel | MOption exercise Restricted Stock Unitsderivative | -10,774 | $0.00 | $0 | 10,773 | Feb 2, 2026 |
| Jan 29, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Phantom Share Unitsderivative | -2,873 | $0.00 | $0 | 2,873 | Feb 2, 2026 |
| Jan 29, 2026 | Jeremy Trahan General Counsel | MOption exercise Phantom Share Unitsderivative | -3,591 | $0.00 | $0 | 3,591 | Feb 2, 2026 |
| Jan 29, 2026 | William Frazier Chief Medical Officer | MOption exercise Phantom Share Unitsderivative | -778 | $0.00 | $0 | 778 | Feb 2, 2026 |
| Jan 29, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Phantom Share Unitsderivative | -8,948 | $0.00 | $0 | 8,946 | Feb 2, 2026 |
| Jan 29, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -39,795 | $0.00 | $0 | 39,795 | Feb 2, 2026 |
| Jan 29, 2026 | Michael Moore President | MOption exercise Restricted Stock Unitsderivative | -26,842 | $0.00 | $0 | 26,842 | Feb 2, 2026 |
| Jan 29, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Phantom Share Unitsderivative | -3,265 | $0.00 | $0 | 3,264 | Feb 2, 2026 |
| Jan 29, 2026 | Michael Moore President | MOption exercise Phantom Share Unitsderivative | -8,947 | $0.00 | $0 | 8,947 | Feb 2, 2026 |
| Jan 29, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Phantom Share Unitsderivative | -13,265 | $0.00 | $0 | 13,265 | Feb 2, 2026 |
| Jan 21, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Common Shares | +49,597 | - | - | 338,147 | Jan 23, 2026 |
| Jan 21, 2026 | Michael Moore President | MOption exercise Common Shares | +34,214 | - | - | 178,948 | Jan 23, 2026 |
| Jan 21, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Common Shares | +117,548 | - | - | 409,910 | Jan 23, 2026 |
| Jan 21, 2026 | Jeremy Trahan General Counsel | MOption exercise Common Shares | +14,648 | - | - | 43,440 | Jan 23, 2026 |
| Jan 21, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Common Shares | +11,719 | - | - | 101,651 | Jan 23, 2026 |
| Jan 21, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Common Shares | +13,317 | - | - | 102,769 | Jan 23, 2026 |
| Jan 21, 2026 | William Frazier Chief Medical Officer | MOption exercise Common Shares | +3,401 | - | - | 72,851 | Jan 23, 2026 |
| Jan 21, 2026 | Casey Hoyt Chief Executive Officer | FTax withholding Common Shares | -13,565 | $7.49 | $102k | 324,582 | Jan 23, 2026 |
| Jan 21, 2026 | Michael Moore President | FTax withholding Common Shares | -9,358 | $7.49 | $70k | 169,590 | Jan 23, 2026 |
| Jan 21, 2026 | Jeremy Trahan General Counsel | FTax withholding Common Shares | -4,783 | $7.49 | $36k | 38,657 | Jan 23, 2026 |
| Jan 21, 2026 | William Todd Zehnder Chief Operating Officer | FTax withholding Common Shares | -35,075 | $7.49 | $263k | 374,835 | Jan 23, 2026 |
| Jan 21, 2026 | Jerome Cambre Vice President of Sales | FTax withholding Common Shares | -3,827 | $7.49 | $29k | 97,824 | Jan 23, 2026 |
| Jan 21, 2026 | Trae Fitzgerald Chief Financial Officer | FTax withholding Common Shares | -4,246 | $7.49 | $32k | 98,523 | Jan 23, 2026 |
| Jan 21, 2026 | William Frazier Chief Medical Officer | FTax withholding Common Shares | -1,169 | $7.49 | $8,756 | 71,682 | Jan 23, 2026 |
| Jan 21, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Common Shares | +12,400 | - | - | 336,982 | Jan 23, 2026 |
| Jan 21, 2026 | Michael Moore President | MOption exercise Common Shares | +8,554 | - | - | 178,144 | Jan 23, 2026 |
| Jan 21, 2026 | Jeremy Trahan General Counsel | MOption exercise Common Shares | +3,662 | - | - | 42,319 | Jan 23, 2026 |
| Jan 21, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Common Shares | +8,554 | - | - | 383,389 | Jan 23, 2026 |
| Jan 21, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Common Shares | +2,930 | - | - | 100,754 | Jan 23, 2026 |
| Jan 21, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Common Shares | +3,329 | - | - | 101,852 | Jan 23, 2026 |
| Jan 21, 2026 | William Frazier Chief Medical Officer | MOption exercise Common Shares | +850 | - | - | 72,532 | Jan 23, 2026 |
| Jan 21, 2026 | Casey Hoyt Chief Executive Officer | DDisposition to issuer Common Shares | -12,400 | $7.49 | $93k | 324,582 | Jan 23, 2026 |
| Jan 21, 2026 | Michael Moore President | DDisposition to issuer Common Shares | -8,554 | $7.49 | $64k | 169,590 | Jan 23, 2026 |
| Jan 21, 2026 | Jeremy Trahan General Counsel | DDisposition to issuer Common Shares | -3,662 | $7.49 | $27k | 38,657 | Jan 23, 2026 |
| Jan 21, 2026 | William Todd Zehnder Chief Operating Officer | DDisposition to issuer Common Shares | -8,554 | $7.49 | $64k | 374,835 | Jan 23, 2026 |
| Jan 21, 2026 | Jerome Cambre Vice President of Sales | DDisposition to issuer Common Shares | -2,930 | $7.49 | $22k | 97,824 | Jan 23, 2026 |
| Jan 21, 2026 | Trae Fitzgerald Chief Financial Officer | DDisposition to issuer Common Shares | -3,329 | $7.49 | $25k | 98,523 | Jan 23, 2026 |
| Jan 21, 2026 | William Frazier Chief Medical Officer | DDisposition to issuer Common Shares | -850 | $7.49 | $6,367 | 71,682 | Jan 23, 2026 |
| Jan 21, 2026 | Jeremy Trahan General Counsel | MOption exercise Restricted Stock Unitsderivative | -14,648 | $0.00 | $0 | 29,296 | Jan 23, 2026 |
| Jan 21, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -117,548 | $0.00 | $0 | 235,094 | Jan 23, 2026 |
| Jan 21, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Restricted Stock Unitsderivative | -11,719 | $0.00 | $0 | 23,436 | Jan 23, 2026 |
| Jan 21, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -13,317 | $0.00 | $0 | 26,632 | Jan 23, 2026 |
| Jan 21, 2026 | William Frazier Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | -3,401 | $0.00 | $0 | 6,800 | Jan 23, 2026 |
| Jan 21, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -49,597 | $0.00 | $0 | 99,194 | Jan 23, 2026 |
| Jan 21, 2026 | Michael Moore President | MOption exercise Restricted Stock Unitsderivative | -34,214 | $0.00 | $0 | 68,428 | Jan 23, 2026 |
| Jan 21, 2026 | Jeremy Trahan General Counsel | MOption exercise Phantom Share Unitsderivative | -3,662 | - | - | 7,324 | Jan 23, 2026 |
| Jan 21, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Phantom Share Unitsderivative | -8,554 | - | - | 17,107 | Jan 23, 2026 |
| Jan 21, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Phantom Share Unitsderivative | -2,930 | - | - | 5,859 | Jan 23, 2026 |
| Jan 21, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Phantom Share Unitsderivative | -3,329 | - | - | 6,658 | Jan 23, 2026 |
| Jan 21, 2026 | William Frazier Chief Medical Officer | MOption exercise Phantom Share Unitsderivative | -850 | - | - | 1,700 | Jan 23, 2026 |
| Jan 21, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Phantom Share Unitsderivative | -12,400 | - | - | 24,798 | Jan 23, 2026 |
| Jan 21, 2026 | Michael Moore President | MOption exercise Phantom Share Unitsderivative | -8,554 | - | - | 17,107 | Jan 23, 2026 |
| Jan 17, 2026 | Jerome Cambre Vice President of Sales | MOption exercise Common Shares | +8,525 | - | - | 92,716 | Jan 21, 2026 |
| Jan 17, 2026 | Trae Fitzgerald Chief Financial Officer | MOption exercise Common Shares | +9,590 | - | - | 92,584 | Jan 21, 2026 |
| Jan 19, 2026 | William Frazier Chief Medical Officer | AGrant or award Restricted Stock Unitsderivative | +11,690 | $0.00 | $0 | 11,690 | Jan 21, 2026 |
| Jan 17, 2026 | William Todd Zehnder Chief Operating Officer | MOption exercise Common Shares | +26,939 | - | - | 300,912 | Jan 21, 2026 |
| Jan 17, 2026 | Jeremy Trahan General Counsel | MOption exercise Common Shares | +4,884 | - | - | 30,387 | Jan 21, 2026 |
| Jan 17, 2026 | Michael Moore President | MOption exercise Common Shares | +26,939 | - | - | 153,282 | Jan 21, 2026 |
| Jan 17, 2026 | Casey Hoyt Chief Executive Officer | MOption exercise Common Shares | +40,068 | - | - | 300,668 | Jan 21, 2026 |
| Jan 17, 2026 | Trae Fitzgerald Chief Financial Officer | FTax withholding Common Shares | -3,132 | $7.33 | $23k | 89,452 | Jan 21, 2026 |
| Jan 17, 2026 | Jerome Cambre Vice President of Sales | FTax withholding Common Shares | -2,784 | $7.33 | $20k | 89,932 | Jan 21, 2026 |
| Jan 19, 2026 | William Frazier Chief Medical Officer | AGrant or award Phantom Share Unitsderivative | +2,922 | $0.00 | $0 | 2,922 | Jan 21, 2026 |
| Jan 17, 2026 | Jeremy Trahan General Counsel | FTax withholding Common Shares | -1,595 | $7.33 | $12k | 28,792 | Jan 21, 2026 |
| Jan 17, 2026 | Michael Moore President | FTax withholding Common Shares | -8,548 | $7.33 | $63k | 144,734 | Jan 21, 2026 |
| Jan 17, 2026 | Casey Hoyt Chief Executive Officer | FTax withholding Common Shares | -12,118 | $7.33 | $89k | 288,550 | Jan 21, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Jerome CambreVice President of Sales
- Randy E. Dobbsdirector
- Trae FitzgeraldChief Financial Officer
- William FrazierChief Medical Officer
- Casey HoytChief Executive Officer
- Nitin Kaushaldirector
- Michael MoorePresident
- Jeremy TrahanGeneral Counsel
- William Todd ZehnderChief Operating Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.